Guardian Pharmacy Services, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Fred Burke
- Full Time Employees
- 3,600
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- 300 Galleria Parkway SE Atlanta GA United States of America 30339
- IPO Date
- Sep 26, 2024
- CIK
- 0001802255
- Website
- guardianpharmacy.com
- Similar Companies
- Business
- Guardian Pharmacy Services, Inc. is a long-term care pharmacy services company headquartered in Nashville, Tennessee, primarily operating across 38 states in the United States. Founded to serve older adults and individuals with complex care needs, the company offers a comprehensive suite of technology-enabled pharmacy services including medication dispensing; clinical pharmacy services; medication management and adherence solutions; smart packaging; robotic dispensing; data analytics through its GuardianShield platform; and personalized pharmacy care tailored to assisted living facilities, behavioral health, post-acute care, hospice, and community care providers. Guardian Pharmacy operates a network of more than 53 pharmacies nationally, serving over 204,000 residents across approximately 8,200 long-term care facilities. Recent major developments include a strategic expansion through acquisitions and new pharmacy launches in 2024 and 2025. The company acquired Heartland Pharmacy in April 2024, Freedom Pharmacy in November 2024, Senior Care Pharmacy in Wichita, Kansas, and Managed Healthcare Pharmacy in Oregon, marking its first presence in the Pacific Northwest. It also opened a new greenfield pharmacy in Naples, Florida, enhancing its geographic footprint and service capabilities. These acquisitions and openings contributed to a 15% year-over-year increase in resident count to approximately 204,000 as of September 2025. Guardian Pharmacy Services also filed a Form S-3 shelf registration in 2025 for potential future capital raises and completed a non-dilutive secondary offering to enhance trading liquidity. The company reported strong financial performance in 2025, raising full-year guidance with revenue projected between $1.43 billion and $1.45 billion and Adjusted EBITDA between $104 million and $106 million. Guardian Pharmacy Services maintains a business model that emphasizes local management of pharmacies supported by a national corporate team, enabling high-touch, personalized care while leveraging advanced technology for operational efficiency and improved clinical outcomes. The company aims to improve medication adherence, reduce hospitalizations, and lower healthcare costs through its integrated pharmacy services. Its client base includes long-term care facilities, senior living communities, and providers supporting intellectually and developmentally disabled individuals, positioning Guardian as a leading LTC pharmacy services provider in the U.S. market. The company continues to pursue growth through acquisitions, operational expansion, and innovative pharmacy services enhancements.
Bessemer Group Inc. Purchases Shares of 78,656 Guardian Pharmacy Services, Inc. $GRDN
Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call
Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts
Bet on Winning DuPont Analysis & Pick 5 Top Stocks
Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?
Guardian Pharmacy Services, Inc. Announces Leadership Transitions
Guardian Pharmacy Services, Inc. (GRDN) Hit a 52 Week High, Can the Run Continue?
Guardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Guardian Pharmacy Services Q1 Earnings Call Highlights
Guardian Pharmacy Services (GRDN) Q1 Earnings and Revenues Surpass Estimates
Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript
Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance
Stevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings Growth
Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Average Recommendation of “Buy” by Analysts
Guardian Pharmacy Services, Inc. to Participate in the Bank of America 2026 Healthcare Conference
Guardian Pharmacy Services, Inc. to Report First Quarter 2026 Financial Results and Host Conference Call
Best Momentum Stocks to Buy for April 10th
New Strong Buy Stocks for April 10th
Earnings Estimates Moving Higher for Guardian Pharmacy (GRDN): Time to Buy?
Guardian Pharmacy (GRDN) Soars 9.1%: Is Further Upside Left in the Stock?